Shionogi and Co ltd - Company & Market Research Reports

Home /
Companies /
Shionogi and Co ltd

Shionogi develops pharmaceutical products for pain, pediatric conditions, infectious diseases, cardiovascular diseases, diabetes, and women's health. It offers products in the form of injections, chewable and oral tablets, capsules, and oral suspensions. It has been expanding its pipeline and its portfolio of marketed products to encompass other therapeutic areas as well, with programs in metabolic conditions and pain management. The company was founded in 2010 and is based in Florham Park, New Jersey.

REFINE BY

KEYWORD

Chronic Refractory Cough - Market Insight, Epidemiology And Market Forecast - 2032

 Report
August 2022
155 Pages
Global

From

€6677EUR$7,500USD£5,771GBP

Irbesartan Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

 Report
February 2024
118 Pages
Global

From

€3500EUR$4,211USD£3,131GBP

Thrombocytopenia - Market Insight, Epidemiology And Market Forecast - 2032

 Report
September 2022
225 Pages
Global

From

€6677EUR$7,500USD£5,771GBP

Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

 Report
September 2023
261 Pages
Global

From

€2226EUR$2,500USD£1,924GBP

DP2 Receptor (G Protein-Coupled Receptor 44 Or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1113EUR$1,250USD£962GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

 Report
May 2019
385 Pages
Global

From

€4006EUR$4,499USD£3,462GBP

Outsourcing in Drug Discovery, 9th Edition

 Report
June 2020
294 Pages
Global

From

€7345EUR$8,250USD£6,348GBP

Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Providers, By Regional Outlook and Forecast, 2021-2027

 Report
February 2022
159 Pages
Global

From

€3205EUR$3,600USD£2,770GBP

Extractables and Leachables Testing Services Market, 2018-2028

 Report
September 2018
200 Pages
Global

From

€3115EUR$3,499USD£2,692GBP

North America Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Providers, By Country and Growth Forecast, 2021-2027

 Report
February 2022
73 Pages
North America

From

€1335EUR$1,500USD£1,154GBP

LAMEA Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Providers, By Country and Growth Forecast, 2021-2027

 Report
February 2022
80 Pages
Africa, Middle East

From

€1335EUR$1,500USD£1,154GBP

Europe Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Providers, By Country and Growth Forecast, 2021-2027

 Report
February 2022
80 Pages
Europe

From

€1335EUR$1,500USD£1,154GBP

Asia Pacific Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Providers, By Country and Growth Forecast, 2021-2027

 Report
February 2022
80 Pages
Asia Pacific

From

€1335EUR$1,500USD£1,154GBP

Osteoarthritis - Pipeline Review, H2 2020

 Drug Pipelines
August 2020
384 Pages
Global

From

€1781EUR$2,000USD£1,539GBP

Fetzima (levomilnacipran; Allergan) Drug Overview 2019

 Report
March 2019
17 Pages
Global

€8903EUR$10,000USD£7,694GBP

Spinocerebellar Ataxia (SCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
September 2022
91 Pages
Global

From

€1781EUR$2,000USD£1,539GBP

Stroke - Pipeline Review, H2 2020

 Drug Pipelines
October 2020
773 Pages
Global

From

€1781EUR$2,000USD£1,539GBP

Seasonal Influenza: Competitive Landscape to 2026

 Report
November 2018
49 Pages
Global

From

€3112EUR$3,495USD£2,689GBP

Head And Neck Cancer - Pipeline Review, H2 2020

 Drug Pipelines
October 2020
3419 Pages
Global

From

€1781EUR$2,000USD£1,539GBP

Investigation Report on China's Rosuvastatin Market, 2018-2022

 Report
November 2018
30 Pages
China

From

€1959EUR$2,200USD£1,693GBP

204 Results (Page 10 of 11)
- 1
- 8
- 9
- 10
- 11

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.